Table 3.
Percentage and odds ratios (CI 95%) for metabolic syndrome (MetS) components and cardiovascular risk (CVR) in euthyroid post-menopausal women grouped considering the presence of MetS and triiodothyronine (T3) concentration
| Without MetS n=33 | MetS-T3Q1 n=22 | MetS-T3Q2 n=21 | MetS-T3Q3 n=21 | MetS-T3Q4 n=23 | |
|---|---|---|---|---|---|
| Waist circumference | 30.3% | 45.5% | 66.7% | 85.7% | 82.6% |
| REF | 2.8 (0.8-9.7) | 6.4 (1.7-23.5)** | 16.2 (3.6-72.8)*** | 12.7 (3.0-53.3)*** | |
| Arterial tension | 30.3% | 72.7% | 81.0% | 61.9% | 69.5% |
| REF | 5.7 (1.6-19.2)** | 10.0 (2.6-38.6)*** | 4.1 (1.2-13.3)* | 6.2 (1.8-21.0)** | |
| Hyperglycemia | 27.3% | 95.5% | 85.7% | 66.7% | 65.2% |
| REF | 53.8 (6.2-462.2)*** | 15.8 (3.7-67.4)*** | 5.4 (1.6-18.1)** | 5.2 (1.6-16.9)** | |
| Triglycerides | 24.2% | 72.7% | 52.4% | 57.1% | 65.2% |
| REF | 8.0 (2.3-27.8)** | 3.3 (1.0-10.9)* | 4.2 (1.3-13.7)* | 6.0 (1.8-19.6)** | |
| Low HDL-C | 54.5% | 76.2%(21) | 76.2% | 95.2% | 85.7% (21) |
| REF | 2.8 (0.8-9.5) | 2.7 (0.8-9.2) | 16.4 (1.9-137.6)* | 4.9 (1.2-20.0)* | |
| HOMA-IR | 24.2% | 36.3% | 66.7% | 66.7% | 78.2% |
| REF | 2.4 (0.6-8.5) | 8.3 (2.2-30.5)*** | 6.8 (1.9-24.2)** | 12.3 (3.2-47.1)*** | |
| CVR moderate/high | 6.1% | 45.5%(21) | 52.4% | 47.6% | 19.0%(21) |
| REF | 14.6 (2.7-78.6)*** | 17.4 (3.2-92.9)*** | 14.0 (2.6-74.3)** | 3.5 (0.5-21.7) |
Binomial logistic regression was applied adjusting age was for all cases. HDL-C, HDL cholesterol; HOMA-IR, insulin resistance. *P ≤ 0.05, **P < 0.01, and ***P < 0.001. Note: HDL-C was not possible to be measure for all women. Numbers into superscript parenthesis together to prevalence for groups MetS-T3Q1 and MetS-T3Q4 indicate the number of participants for HDL-C and CVR.